FIELD: immunology, biochemistry. SUBSTANCE: protein is isolated from bacterial strain Moraxella catarrhalis, cellular lysate obtained by disruption of cellular mass of bacterial strain is fractionated by centrifugation for preparing precipitate and supernatant. Precipitate is extracted selectively to remove residual soluble proteins, membrane proteins and other proteins differing from protein CD and other contaminating impurities. The remaining CD-containing precipitate is dispersed, solubilized and then fractionated by centrifugation to remove cellular residue. The strain Moraxella catarrhalis RH 408 is used for preparing protein CD of external membrane. Protein CD is used in immunogenic compositions, in part, for administration to patient in vivo. Invention ensures to develop the protection against diseases caused by bacterial pathogen which produces protein CD or protein that is able to induce antibodies in recipient and showing specific reaction with protein CD. EFFECT: improved method of isolation and purification of protein, valuable medicinal properties. 15 cl, 8 dwg, 1 tbl, 8 ex
Title |
Year |
Author |
Number |
GENES ENCODING MORAXELLA TRANSFERRIN RECEPTOR |
1997 |
- Majers Lajza E.
- Shrivers Ehntoni B.
- Khehrkness Robin E.
- Lusmor Shina M.
- Du Ran-Pehn
- Jang Jan-Ping
- Klajn Majkl Kh.
|
RU2235128C2 |
DNA FRAGMENT ENCODING TRANSFERRIN RECEPTOR PROTEIN FRAGMENT OF STRAIN HAEMOPHILUS (VARIANTS), PLASMID VECTOR (VARIANTS), RECOMBINANT PROTEIN (VARIANTS), ISOLATED AND PURIFIED PROTEIN (VARIANTS), IMMUNOGENIC COMPOSITION AND METHOD OF ISOLATION AND PURIFICATION OF PROTEIN |
1994 |
- Luzmor Shina
- Kharkness Robin
- Shriverz Ehntoni
- Chong Pele
- Grej-Ouehn Skott
- Jang Jan-Ping
- Merdin Ehndrju
- Klejn Majkl
|
RU2194757C2 |
PURIFIED AND ISOLATED NUCLEIC ACID MOLECULE, RECOMBINANT PLASMID, RECOMBINANT VECTOR, PURIFIED AND ISOLATED PROTEIN, PURIFIED AND ISOLATED PROTEIN D15 OR ITS PART OF EXTERNAL ENVELOPE, SYNTHETIC PEPTIDE, CHIMERIC MOLECULE, IMMUNOGENIC COMPOSITION AND ANTISERUM OR ANTIBODY |
1993 |
- Pele Chong
- Vejn Tomas
- Jan-Ping Jang
- Shina Lusmore
- Du Juan Charlz Sia
- Majkl Klejn
|
RU2141528C1 |
HYBRID PROTEIN, HYBRID GENE, METHOD OF PREPARING A HYBRID PROTEIN, VACCINE AGAINST UPPER RESPIRATORY WAY VIRAL DISEASE, BACULOVIRAL EXPRESSION VECTOR (VARIANTS) |
1993 |
- Mishel Kh.Klejn
- Run-Pan Du
- Meri E.Ehvazishin
|
RU2123047C1 |
ANALOGUE HIN47 OF HAEMOPHILUS WITH REDUCED PROTEASE ACTIVITY |
1995 |
- Luzmor Shina M.
- Jang Jan-Ping
- Chong Pele
- Oomen Rejmond P.
- Kljajn Mishel' Kh.
|
RU2196176C2 |
RESPIRATORY-SYNCYTIAL VIRUS SUBUNIT VACCINE PREPARATION |
1997 |
- Kejts Dzhordzh A.
- Sanuehza Sonja E.
- Oomen Rajmond P.
- Klajn Mishel' Kh.
|
RU2243234C2 |
INACTIVATED VACCINES OF RESPIRATORY-SYNTYTIAL VIRUS |
1994 |
- Sonja E.Sankhuehza
- Mehri Ehlizabet Ivasishin
- Michel Genri Klejn
|
RU2142817C1 |
SYNTHETIC PEPTIDE, SYNTHETIC LIPOPEPTIDE, IMMUNOGENIC CONJUGATE (VARIANTS), METHOD OF OLIGOMER PREPARING, POLYSACCHARIDE PROTECTED BY SOLID POLYETHYLENE GLYCOL MONOMETHYL ESTER |
1993 |
- Pele Chong
- Ali Kandil
- Charl'Z Saja
- Majkl Kh.Klejn
|
RU2141527C1 |
POLYVALENT ASSOCIATED DIPHTHERIA, TETANUS TOXOIDS AND PERTUSSIS POLIOVIRUS VACCINES |
1997 |
- Fakhim Raafat E.F.
- Tehn Lehrri Ju.L.
- Barreto L'Juis
- Tippkhavong Dzhon
- Dzhekson Gejl E.D.
|
RU2194531C2 |
SYNTHETIC HIV PEPTIDE (VARIANTS), IMMUNOGENIC COMPOSITION FOR INDUCTION OF IMMUNE RESPONSE AGAINST HIV PEPTIDES, DIAGNOSTIC SET FOR ASSAY OF HIV-SPECIFIC ANTIBODIES |
1994 |
- Sia Charlz D.I.
- Chong Pele
- Klejn Majkl Kh.
|
RU2201421C2 |